FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma
Head & Neck · 2026-11-15
DOI: 10.1002/hed.70545 ↗At a glance
Journal article in Head & Neck, published online on 2026-11-15. Written by Shuang Teng and 11 co-authors. Institution: Department of Otolaryngology, Head and Neck Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China. 20 references. Funded by: National Natural Science Foundation of China, Wuyuan Research Fund of the Fifth Affiliated Hospital of Harbin Medical University.
Abstract (original language)
Background
Fibrinogen‐like protein 1 (FGL1) is involved in tumor progression and immune regulation, but its role in laryngeal squamous cell carcinoma (LSCC) is unclear.
Methods
Plasma FGL1 levels were measured in 120 LSCC patients and 50 controls using ELISA. Tissue expression was analyzed via TCGA‐HNSC. Functional assays evaluated proliferation, migration, invasion, apoptosis, and cisplatin sensitivity. Prognostic value was assessed using survival and regression analyses.
Results
FGL1 was significantly elevated in LSCC plasma and tumor tissues. Functional studies showed that FGL1 promotes proliferation, migration, invasion, and EMT while inhibiting apoptosis and enhancing cisplatin resistance. Mechanistically, FGL1 knockdown increased Cleaved Caspase‐3 and decreased Bcl‐2 expression. High FGL1 levels were associated with poorer overall survival and independently predicted prognosis.
Conclusion
FGL1 promotes LSCC progression and chemoresistance, highlighting its potential as a circulating biomarker and therapeutic target.
Subjects
Author keywords
Authors and institutions
- Department of Otolaryngology, Head and Neck Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Otolaryngology, Head and Neck Surgery, Fifth Affiliated Hospital, Harbin Medical University, Daqing, Heilongjiang, China.
ORCID profiles: Shuang Teng, Shuo Liu, Rui Zhao, Ya-Nan Sun
Funding
- National Natural Science Foundation of China
- Wuyuan Research Fund of the Fifth Affiliated Hospital of Harbin Medical University
Cite
APA
Teng, S., Jin, M., Yan, B. R., Qu, L. M., Xu, Z. N., Liu, S., Li, Q. Y., Zhang, F. S., Hao, Q., Guo, S., Zhao, R., & Sun, Y. N. (2026). FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.70545
Vancouver
Teng S, Jin M, Yan BR, Qu LM, Xu ZN, Liu S, et al. FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma. Head & Neck. 2026. doi:10.1002/hed.70545
BibTeX
@article{Teng2026,
author = {Teng, Shuang and Jin, Meng and Yan, Bing-Rui and Qu, Ling-Mei and Xu, Zhao-Nan and Liu, Shuo and Li, Qiu-Ying and Zhang, Feng-Shuo and Hao, Qing and Guo, Shuang and Zhao, Rui and Sun, Ya-Nan},
title = {FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70545}
}
EUVIMED